Should more patients with acute ischaemic stroke receive thrombolytic treatment?
Wardlaw
Joanna M
JM
Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU. joanna.wardlaw@ed.ac.uk
Sandercock
Peter A G
PA
Murray
Veronica
V
D035843:Biomedical Research; D002545:Brain Ischemia / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator